MedTrace Logo

Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation

NCT02541617 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-04-27

No results posted yet for this study

Summary

Outcomes study to test the hypothesis that patients first identified by community-based neurologists, implanted by a networked movement disorders center, and then managed by the same community-based neurologist will have clinical outcomes comparable to movement disorders centers.

Conditions

Interventions

PROCEDURE

Programming by community Neurologist

Deep Brain stimulator with be programmed by a community Neurologist

PROCEDURE

Standard of care

Deep Brain Stimulator will be programmed with at the implanting movement disorders center

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Fenna T Phibbs, MD · Vanderbilt Univeristy Medical center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-02-28
Completion
2018-02-28

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02541617 on ClinicalTrials.gov